We're in the year of the biotech buyout, and here are five prime targets

We're in the year of the biotech buyout, and here are five prime targets


If Princess Leia were a biotechnology investor, she'd be chanting: "Help me, mergers and acquisitions, you're my only hope." This little snippet of Wall Street gallows humor comes from Baird biotech analyst Brian Skorney - his stab at taking some of the edge off the sturm und drang that investors feel about a sector that just keeps getting pounded by concerns about politicians whacking drug prices.



from Biotech News